Venture Atlas Labs

What Venture Atlas Labs does

Venture Atlas Labs is a private, founder-led consultancy and education business headquartered in Austin, Texas with a secondary office in Tallinn, Estonia. The company helps international healthtech, medtech, and clinical software companies—primarily from the EU and ANZ regions—navigate US market entry and commercialization. With a team of 1-10 employees, the company serves international healthtech scaleups with product traction in their home markets, alongside investors (VC, PE, CVC, family offices), trade agencies, innovation clusters, corporate innovation units, and government policymakers.

The company's core product portfolio spans three pillars: (1) Programs including the HealthTech Bridge co-run accelerator with HTA (offering guaranteed US hospital pilots), the SCALE commercial partner matching service, and the Capital Network for deal syndication; (2) Educational products including virtual courses (US Commercialization 101, Uncertainty and Decision-Making under Fire, Scaling to Europe 101, Engineering Adoption), in-person workshops, and the twice-monthly Current Affairs briefings; and (3) Advisory services delivered through the seasonal Boardroom membership and customized consulting engagements. Two proprietary methodologies underpin the offering: the CLEAR/IT framework for decisions under uncertainty, and the SCALE fingerprint matching system for partner matching. There is no proprietary software platform.

The business model is multi-stream and services-based: course fees ($49-$1,200), seasonal Boardroom subscriptions ($2,500/season), Capital Network application fees ($150) and syndication arrangements, consulting credits, and accelerator participation. The company generates revenue primarily in USD and EUR, with group discounts for 3+ participants and partner discount codes distributed through trade agencies, clusters, science parks, and universities. Go-to-market is sales-led and event-driven, relying on LinkedIn, email newsletters, educational content, and partner referrals. No funding rounds have been disclosed, and the company operates independently without institutional investors.

Name

Venture Atlas Labs

Legal name

Venture Atlas Labs

Website

https://ventureatlaslabs.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Venture Atlas Labs is a private Austin-based consultancy and education firm that helps international healthtech and medtech companies—primarily from the EU and ANZ—enter and scale into the US market through courses, workshops, boardroom advisory, partner matching, and an accelerator with hospital pilots.

Ownership category

akta.pro rank

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Educational Courses and Workshops: Virtual courses ($49-$1,200), in-person workshops (half-day, full-day, multi-day), and intensive programs delivered to international healthcare entrepreneurs. Revenue from course fees, season passes, and single session tickets.
2. Boardroom Membership Program: Seasonal membership ($2,500/season) providing weekly deep-dive sessions, featured sessions with sales and hospital procurement leaders, 1:1 sessions, and Current Affairs access.
3. Capital Network: Reviews, conducts due diligence, and syndicates early-stage deals monthly. Application fee of $150 for feedback; syndication and deal memo services for selected companies.
4. Consulting and Advisory Services: Credits-based consulting program for companies, investors, and law firms. Custom research and strategy projects, deal scouting, due diligence, and expert opinions.
5. HealthTech Bridge Accelerator: Co-run accelerator with HTA providing clinical and commercial acceleration for international startups to enter US market. Includes guaranteed hospital pilots and commercialization support.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels5 records

Core offering

Venture Atlas Labs is a boutique advisory and education firm that helps international (primarily EU and ANZ) healthtech and medtech scaleups enter and scale in the US market. Its offerings span virtual courses, in-person workshops, a seasonal Boardroom membership, the SCALE commercial partnering program, the Capital Network investment syndication, and the HealthTech Bridge accelerator co-run with HTA. Core deliverables are strategic clarity, US commercial partner matching, and facilitation of guaranteed US hospital pilots.

Product overview

Venture Atlas Labs is a services and education company that helps international healthcare companies (primarily EU and ANZ) navigate US market entry and commercialization. The portfolio consists of three core pillars: (1) Programs including the HealthTech Bridge accelerator (with guaranteed US hospital pilots), SCALE commercial partnering, and Capital Network for investment syndication; (2) Learning products including virtual courses (US Commercialization 101, Uncertainty + Decision-Making under Fire, Scaling to Europe 101, Engineering Adoption) and in-person workshops covering transatlantic commercialization, investment access, and risk management; and (3) Advisory services including Current Affairs briefings and Boardroom sessions. The company does not offer a unified software platform but rather a modular suite of educational, advisory, and facilitation services designed for healthtech/medtech companies at various stages of US market evaluation and entry.

Differentiator

Problem solved

Functional benefit

Brands

• HealthTech Bridge: A clinical and commercial acceleration program co-run with HTA designed for international startups to enter the US with guaranteed hospital pilots. Focus areas include cardiometabolic health innovations for underserved rural populations.

Products and services

• HealthTech Bridge An accelerator specifically designed for international healthtech startups to enter the US market with guaranteed hospital pilots, providing tailored information, commercialization strategy, and clinical validation opportunities. Co-run with HTA.
• SCALE Commercial partnering and procurement matching service that uses a proprietary fingerprint system to match scaleups with US strategic partners in clinical workflow for mutual benefit. Currently focused on cardiology, radiology, in vitro diagnostics, diagnostic imaging, and surgical medical devices.
• Capital Network A network of US angels and funds that reviews, conducts due diligence, and syndicates early-stage deals monthly. Investment thesis focuses on B2B healthcare companies from outside the US with external clinical and technical validation ready to enter the US within 6 months, with particular interest in cardiology, in vitro diagnostics, diagnostic imaging, oncology, and women's health. Sweet spot of $1-3.5M USD.
• Current Affairs Twice monthly meetings that provide signal over noise on what is happening in the US healthcare landscape. Topics range from regulatory, reimbursement, economics, policy, adoption practices, geopolitics, tariffs, supply chain changes, investment requirements, and security/compliance shifts. H1 2026 Season runs February through June 2026 at $300 for a season pass or $49 for a single pass.
• Boardroom A private, practical working room for commercial expansion decisions facing executives evaluating US entry and scaling. Seasonal program with weekly sessions covering topics like generating revenue before reimbursement, value analysis committees, revenue waterfalls, pilot-to-paid engineering, and pricing. Spring 2026 Season costs $2,500/€2,100 for full access to six sessions plus two special featured sessions. Drop-in tickets available at $350/€294 per session.
• US Commercialization 101 Four virtual sessions providing foundations of US healthcare commercialization for entrepreneurs. Covers how US systems work from fee-for-service to value-based care, buyer map, health economics, evidence requirements, and go-to-market paths. Includes one private 1:1 sparring session. Cost: $1,200/€1,015.
• Uncertainty + Decision-Making under Fire A 2-hour live virtual intensive teaching the CLEAR/IT framework for making high-stakes decisions with incomplete information under pressure. Designed for founders, CEOs, commercial leads, and operators making high-stakes calls. Cost: $149/€126.
• Scaling to Europe 101 Course covering what awaits healthcare scaleups scaling into the EU, including candid insights into healthcare models, entry requirements, and reimbursement pathways. Scheduled for April 10 with application required.
• Engineering Adoption Course teaching how adoption is truly built in the US healthcare market in 2026. Covers how value, pricing, and payment models align so clinical, operational, and economic benefits translate into decisions buyers can approve. Scheduled for April 17 with application required.
• In-Person Workshops Half-day, full-day, and multi-day intensive workshops on European value propositions in the US market, including Transatlantic Commercialization, Access to Investment, Risk and Strategic Thinking, CLEAR/IT framework methodology, and topics covering business model fit, US health economics, fundraising, reimbursement, sales structure, investment narrative, and pricing. Tailored to specific therapeutic areas, modalities, stages, and regions.
• Strategy Services Four service formats: (1) Consulting credits for companies, investors, and law firms; (2) Workshops for clusters, governments, and investors in 1-hour, 4-hour, and 6-hour increments covering US commercialization, sales strategy, and market entry risk mitigation; (3) Deal scouting, due diligence, and expert opinions for investors and corporations; (4) Custom research and strategy for US commercial pathways. Also serves trade agencies, research clusters, corporate innovation units, early-stage startups, and law firms.

Quantifiable outcome

• Companies have attractive businesses in both US and home region, making for credible investment opportunities
• +1 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• HTA (Health Technology Association)coreStrategic or Co-development Partner · 5 March 2026Co-running HealthTech Bridge accelerator program designed to help international health technology companies navigate and enter the U.S. healthcare market through structured clinical validation opportunities and commercialization support. The program builds on HTA's decade-long track record of facilitating real-world clinical partnerships.
• ENRICH (European Network of Research Innovation Centres and Hubs)coreStrategic or Co-development PartnerElizabeth Jennings serves as healthtech lead at ENRICH, supporting European entrepreneurs' soft landing into 18 hubs across the US. Partnership provides access to international innovation ecosystem and referral pipeline.
• SWAN Impact (Business Angel Network)minorStrategic or Co-development PartnerElizabeth Jennings serves on the Board of Directors focusing on impact-driven healthcare startup investments. Connection to impact investing network for deal flow and expertise.
• Texas Medical Center | Denmark BioBridgeminorStrategic or Co-development PartnerInternational MoU signed by TMC and Kingdom of Denmark. Co-founded and chaired by Christina Brinch Clark as advisor to Ministry of Foreign Affairs of Denmark.
• OEMs, Sales Agents, and Distributors (via SCALE)coreChannel Partner/ Reseller/ DistributorSCALE program matches strategic partners (OEMs, sales agents, distributors, corporations) with scaleups for mutual benefit. Partners are in specific service lines for cardiology, radiology, in vitro diagnostics, diagnostic imaging, and surgical medical devices.
• Trade Agencies, Clusters, Science Parks, and UniversitiesminorChannel Partner/ Reseller/ DistributorPartner organizations that provide discount codes to their member companies for Venture Atlas Labs courses and programs. Referral pipeline for course enrollments and program applications.
• US Healthcare Systems and ProviderscoreStrategic or Co-development PartnerRelationships with healthcare systems across the US inform insights, advice, and knowledge shared with clients. Network used for pilot opportunities, procurement insights, and real-world case studies.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• MedTech Innovator: US-based accelerator for medical device and healthtech startups, including international cohorts. Closely comparable to Venture Atlas Labs through its HealthTech Bridge accelerator offering structured clinical validation and commercialization pathways for medtech startups.
• Xcenda (Cencora): Pharmaceutical and biotech market access consulting firm (now part of Cencora). Directly comparable to VAL's commercialization strategy, market access, and payer/provider advisory work for healthcare companies entering new markets.
• Evidera (Thermo Fisher / PPD): Health economics, outcomes research, and market access consulting firm operating globally. Comparable to VAL through its evidence-and-market access advisory work for healthcare innovators pursuing US and international commercial expansion.

Others

• HIMSS: Global healthcare IT membership, education, and conference organization. Comparable to VAL through its educational programs and community-building role in healthcare innovation, though it does not provide direct commercialization advisory services.
• HealthTech Capital: US-based angel and early-stage investor network focused on health technology and medical device companies. Directly comparable to VAL's Capital Network in providing early-stage investment pathways for international healthtech companies seeking US entry.

Broad incumbents

• Bain & Company (Healthcare Practice): Global strategy consultancy with a leading healthcare practice serving biopharma, medtech, and providers on commercial strategy and market access. Comparable incumbent offering the same strategic entry advisory work as VAL at greater scale.
• McKinsey & Company (Healthcare Practice): The largest global strategy consultancy with a major healthcare practice serving providers, payers, and medtech on market entry, growth strategy, and operations. Represents the scaled incumbent end of VAL's competitive set.
• ZS Associates: Global consulting firm with a dedicated healthcare practice focused on commercial strategy, sales, and analytics for pharma, medtech, and healthtech. Comparable to VAL through its commercialization strategy and market access work for healthcare entrants.
• L.E.K. Consulting: Global strategy consultancy with a deeply established healthcare and life sciences practice serving biopharma, medtech, and digital health clients on market entry, pricing, and commercial strategy. A scaled incumbent competitor in VAL's exact service category.

Regional players

• ANDHealth: Australia-based digital health accelerator and commercialization program supporting ANZ healthtech companies. Comparable to VAL through shared focus on ANZ-origin healthtech expansion and clinical validation pathways, though it does not directly compete in the US market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights1 record

Customer concentration

• LinkedInlinkedin.com/company/ventureatlaslabs

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Venture Atlas Labs